Bridge the Gap - SYNGAP Education and Research Foundation is excited to announce we will be hosting SYNGAP1: Drug Development Meeting
Learn more about why this EL-PFDD Meeting is a critical step in our strategy to help help accelerate the research pathway toward new therapeutic treatments for those affected by SYNGAP1. Learn more about Externally Led -Patient Focused Drug Development Meetings on the FDA PFDD Website
Check out what other patient advocacy organizations are sharing about their experiences and how they benefited from hosting an Externally Led - PFDD Meeting - Here: Taking Stock of PFDD: A Vibrant Future for Patient-Focused Drug Development.
BTG's EL-PFDD Meeting will be held as a virtual, live-stream event, that is accessible and free to all SYNGAP1 Community Stakeholders. The meeting will have guest moderators and include a participating panel of SYNGAP1 patients/families/caregivers, families; SYNGAP1 clinical/research experts and regulatory experts. Virtual attendees will have opportunities to ask questions and provide comments during the meeting and for 30 days post-meeting.
Please contact us with any questions you may have regarding this meeting.